Session 210: Registration Trials versus Clinical Practice: Challenges Associated with Newly Approved Antimicrobials
The IDWeek 2019 Digital Library is intended as a resource to view IDWeek sessions virtually and claim CME credit. If you plan to claim CME credit for a session, please ensure you have first watched the session video in the DIGITAL LIBRARY prior to completing the evaluation form.
Faculty and Disclosures
Yohei Doi MD, PhD, Associate Professor of Medicine, University of Pittsburgh, COI Disclosures: Nothing to disclose
Cesar Arias, MD, MSc, PhD; Professor University of Texas Health Science Center, COI Disclosures: "American Society for Microbiology: Fees for Editor of Antimicrobial Agents and Chemotherapy. Money paid to University, Other Financial or Material Support, Entasis Pharmaceuticals: Grant/Research Support, Research Grant MeMed Diagnostics: Grant/Research Support, Research Grant Merck: Grant/Research Support, Research Grant UptoDate: Other Financial or Material Support, Royalties from a Chapter"
Lindsey Baden, MD, MSc; Attending Physician Brigham and Women's Hospital, COI Disclosures: Nothing to disclose
Sumathi Nambiar, MD, MPH Division Director Food and Drug Administration, COI Disclosures: Nothing to disclose
IDSA is accredited by the Accreditation Council for Continuing Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
IDSA designates this enduring material for a maximum of 25.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit(s)™